A Phase Ib Study of GC101 in NSCLC

Clinical trial NCT06473961 · RECRUITING

Trial details

NCT number: NCT06473961
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer

Start date: 2024-10-14
Primary completion: 2027-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.